284
Views
4
CrossRef citations to date
0
Altmetric
Review

Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agents

, , &
Pages 151-162 | Received 20 Jun 2016, Accepted 09 Dec 2016, Published online: 29 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Camillo Porta, Silvia Chiellino, Alessandra Ferrari, Sara Mariucci & Wanda Liguigli. (2017) Pharmacotherapy for treating metastatic clear cell renal cell carcinoma. Expert Opinion on Pharmacotherapy 18:2, pages 205-216.
Read now

Articles from other publishers (3)

Sergio Bracarda, Camillo Porta, Roberto Sabbatini & Licia Rivoltini. (2019) Angiogenic and immunological pathways in metastatic renal cell carcinoma: A counteracting paradigm or two faces of the same medal? The GIANUS Review. Critical Reviews in Oncology/Hematology 139, pages 149-157.
Crossref
Peter J. Goebell, Michael Staehler, Lothar Müller, Arnd Nusch, Michael Scheffler, Annette Sauer, Ulla von Verschuer, Susanne Tech, Lisa Kruggel, Martina Jänicke & Norbert Marschner. (2018) Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma – Analyses From the German Clinical RCC-Registry. Clinical Genitourinary Cancer 16:6, pages e1101-e1115.
Crossref
A Murakami, L Wang, S Kalhorn, P Schraml, W K Rathmell, A C Tan, R Nemenoff, K Stenmark, B-H Jiang, M E Reyland, L Heasley & C-J Hu. (2017) Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma. Oncogenesis 6:1, pages e287-e287.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.